Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this follow-up study is to look carefully at the long-term course of multiple
sclerosis (MS) and possibly the long-term effects of Betaseron in the patients who were
previously enrolled in the original North American study that led to the marketing approval
of Betaseron.